The Hidden Differences Between Oral Contraceptives

National adverse-event and prescribing data suggest oral contraceptive formulations differ in reported acne, migraine, anxiety, and depression

Category	Detail
Condition	Oral contraceptive side effects
Key Mechanisms	Variations in progestin components and pharmacologic properties across formulations
Target Population	Women using oral contraceptives
Care Setting	Outpatient, primary care, and gynecology

Higher rates of acne reported with drospirenone, levonorgestrel, and norgestimate formulations
Drospirenone linked to increased rates of migraine and depression
Anxiety reports varied, with higher rates in levonorgestrel and desogestrel users
Norethindrone-only pills associated with lower anxiety rates
Overall low depression rates across most formulations

Monitor for dermatologic and mood-related symptoms in patients using oral contraceptives

Consider formulation-specific side-effect profiles when prescribing oral contraceptives

Assess patient-reported side effects regularly, particularly for acne, migraine, anxiety, and depression

Be aware of potential increased side effects associated with specific progestin formulations

Women of reproductive age using oral contraceptives

Formulation choice may need to be tailored based on individual patient health conditions and side effect profiles

Utilize adverse-event reporting data to inform contraceptive choices
Engage in shared decision-making with patients regarding contraceptive options
Educate patients on potential side effects associated with different formulations